What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

por Šíma, Martin, Michaličková, Danica, Slanař, Ondřej
Publicado 2021

Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets

por Ľupták, Matej, Michaličková, Danica, Fišar, Zdeněk, Kitzlerová, Eva, Hroudová, Jana
Publicado 2021

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation

por Šantavý, Petr, Šíma, Martin, Zuščich, Ondřej, Kubíčková, Vendula, Michaličková, Danica, Slanař, Ondřej, Urbánek, Karel
Publicado 2022

Profiling of microorganism-binding serum antibody specificities in professional athletes

por Minić, Rajna, Papić, Zlatko, Đorđević, Brižita, Michaličkova, Danica, Ilić, Vesna, Mathiesen, Geir, Živković, Irena, Pantic, Visnja, Dimitrijević, Ljiljana
Publicado 2018

Effects of Probiotic Supplementation on Selected Parameters of Blood Prooxidant‐Antioxidant Balance in Elite Athletes: A Double‐Blind Randomized Placebo‐Controlled Study

por Michalickova, Danica, Kotur-Stevuljevic, Jelena, Miljkovic, Milica, Dikic, Nenad, Kostic-Vucicevic, Marija, Andjelkovic, Marija, Koricanac, Vladimir, Djordjevic, Brizita
Publicado 2018

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses

por Šíma, Martin, Michaličková, Danica, Ryšánek, Pavel, Cihlářová, Petra, Kuchař, Martin, Lžičařová, Daniela, Beroušek, Jan, Hartinger, Jan Miroslav, Vymazal, Tomáš, Slanař, Ondřej
Publicado 2021

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications

por Hartinger, Jan Miroslav, Michaličková, Danica, Dvořáčková, Eliška, Hronová, Karolína, Krekels, Elke H. J., Szonowská, Barbora, Bednářová, Vladimíra, Benáková, Hana, Kroneislová, Gabriela, Závora, Jan, Tesař, Vladimír, Slanař, Ondřej
Publicado 2023

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

por Michaličková, Danica, Jansa, Pavel, Bursová, Miroslava, Hložek, Tomáš, Čabala, Radomír, Hartinger, Jan Miroslav, Ambrož, David, Aschermann, Michael, Lindner, Jaroslav, Linhart, Aleš, Slanař, Ondřej, Krekels, Elke H.J.
Publicado 2020